WAKUNAGA Trademark

Trademark Overview


On Thursday, September 17, 2020, a trademark application was filed for WAKUNAGA with the United States Patent and Trademark Office. The USPTO has given the WAKUNAGA trademark a serial number of 79303290. The federal status of this trademark filing is REGISTERED as of Tuesday, October 5, 2021. This trademark is owned by Wakunaga Pharmaceutical Co., Ltd.. The WAKUNAGA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations in the nature of anti-tussive expectorants, analgesics, anti-inflammatories, eye drops, and topical dermatological preparations for the treatment of gastrointestinal diseases, colds, rhinitis, hemorrhoids, dermatitis and eczema; Chinese traditional medicinal herbs; reagent paper for medical purposes; adhesive tapes for medical purposes; gauze for dressings; medicated compresses; capsules sold empty for pharmaceuticals; eyepatches for medical purposes; sanitary tampons; sanitary pads; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; breast-nursing pads; cotton swabs for medical purposes; teeth filling material; babies' diapers; napkins for incontinents; fly catching paper; mothproofing paper; lacteal flour for babies; nutritional supplements; dietary supplements for animals; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; food for babies; nutr...
wakunaga

General Information


Serial Number79303290
Word MarkWAKUNAGA
Filing DateThursday, September 17, 2020
Status700 - REGISTERED
Status DateTuesday, October 5, 2021
Registration Number6504735
Registration DateTuesday, October 5, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 20, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations in the nature of anti-tussive expectorants, analgesics, anti-inflammatories, eye drops, and topical dermatological preparations for the treatment of gastrointestinal diseases, colds, rhinitis, hemorrhoids, dermatitis and eczema; Chinese traditional medicinal herbs; reagent paper for medical purposes; adhesive tapes for medical purposes; gauze for dressings; medicated compresses; capsules sold empty for pharmaceuticals; eyepatches for medical purposes; sanitary tampons; sanitary pads; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; breast-nursing pads; cotton swabs for medical purposes; teeth filling material; babies' diapers; napkins for incontinents; fly catching paper; mothproofing paper; lacteal flour for babies; nutritional supplements; dietary supplements for animals; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; food for babies; nutraceutical preparations for use as a dietary supplement; semen for artificial insemination; medicated ointments for pharmaceutical purposes, namely, treating dermatological conditions, hemorrhoids, athlete's foot and ringworm; pharmaceutical preparations for skin care; lotions for pharmaceutical purposes, namely, pharmaceutical skin lotions; Medicinal tonics, namely, medicinal drinks; germicides; air purifying preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 5, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameWakunaga Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameWakunaga Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameWakunaga Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Friday, February 5, 2021ASSIGNED TO EXAMINER
Thursday, February 4, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, February 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 5, 2021NON-FINAL ACTION WRITTEN
Saturday, February 6, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, March 7, 2021REFUSAL PROCESSED BY IB
Monday, March 15, 2021FINAL REFUSAL WRITTEN
Tuesday, February 9, 2021APPLICATION FILING RECEIPT MAILED
Thursday, February 18, 2021REFUSAL PROCESSED BY MPU
Thursday, February 18, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, March 5, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 5, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 6, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 17, 2021FINAL REFUSAL MAILED
Wednesday, June 16, 2021EXAMINERS AMENDMENT E-MAILED
Monday, May 24, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, May 24, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 25, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 16, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 16, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 16, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, June 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 30, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 20, 2021PUBLISHED FOR OPPOSITION
Tuesday, July 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 5, 2021REGISTERED-PRINCIPAL REGISTER
Friday, March 25, 2022FINAL DISPOSITION PROCESSED
Friday, July 12, 2024NEW REPRESENTATIVE AT IB RECEIVED
Monday, April 18, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, January 5, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, March 25, 2022FINAL DISPOSITION NOTICE SENT TO IB